Comirnaty 3mcg Concentrate for Dispersion for Injection

Manufacturer
BioNTech Manufacturing GmbH(GERMANY)

Registraction Number
MAL23126035AZ


Content:
Comirnaty 3 mcg Concentrate for Dispersion for Injection contains 30 micrograms of COVID-19 mRNA vaccine (nucleoside-modified) per 0.3 mL dose. The vaccine is designed to prevent COVID-19 caused by the SARS-CoV-2 virus.
Indications:

• Active immunization: Used to prevent COVID-19 in individuals aged 16 years and older.
• Dosage: Administered as a course of two doses (0.3 mL each) at least 21 days apart.

• Dosage: Two doses of 0.3 mL each, administered intramuscularly in the deltoid muscle of the upper arm.
• Administration: Dilute the concentrate before use. Each vial contains enough for six doses after dilution.
• Precautions: Inform your healthcare provider if you have any allergies, a history of severe allergic reactions, or any other health conditions. Monitor for side effects such as fever, fatigue, headache, muscle pain, chills, and injection site reactions.
• Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.